Filter
2071
Text search:
medicine
product
Featured
Recommendations
194
New Publications
515
Language
Document type
No document type
1014
Studies & Reports
411
Guidelines
348
Manuals
141
Strategic & Response Plan
75
Fact sheets
37
Training Material
27
Situation Updates
10
Resource Platforms
6
Infographics
2
Countries / Regions
Global
97
India
72
Ethiopia
58
Kenya
54
South Africa
51
Nigeria
48
Uganda
39
Latin America and the Carribbean
36
Ghana
33
Nepal
31
Liberia
30
Tanzania
30
Malawi
30
Sierra Leone
29
Western and Central Europe
28
Bangladesh
27
Zambia
25
Rwanda
25
Myanmar / Burma
24
Namibia
22
Philippines
19
South–East Asia Region
17
Africa
16
Zimbabwe
15
Syria
13
Ukraine
13
Lesotho
13
Germany
11
East and Southern Africa
11
Congo, Democratic Republic of
10
Cambodia
10
Mozambique
10
Asia
10
Indonesia
9
Eswatini/ Swaziland
9
West and Central Africa
9
Eastern Europe
9
Haiti
8
Botswana
8
Middle East and North Africa
8
Guinea
7
Burkina Faso
7
Senegal
7
Cameroon
7
Vietnam
7
Pakistan
6
China
6
USA
5
South Sudan
5
Afghanistan
5
Thailand
5
Brazil
5
Albania
5
Sudan
4
Benin
4
Yemen
4
Western Pacific Region
4
Eastern Europe and Central Asia
4
Russia
4
United Kingdom
4
Somalia
3
Lebanon
3
Turkey
3
North Macedonia
3
Paraguay
3
Venezuela
3
Moldova
3
Japan
3
Jordan
2
Malaysia
2
Central African Republic
2
Angola
2
Madagascar
2
Fiji
2
Southern Africa
2
Laos
2
Tajikistan
2
Iran
2
Kyrgyzstan
2
Kazakhstan
2
Georgia
2
North America
2
Jamaica
2
Spain
2
Bosnia and Herzegovina
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Chad
1
Gambia
1
Argentina
1
Peru
1
Ecuador
1
Libya
1
Guatemala
1
Sri Lanka
1
Chile
1
Other region
1
Poland
1
Italy
1
Mongolia
1
Qatar
1
Bulgaria
1
Uzbekistan
1
Australia
1
Gabon
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Portugal
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
757
Clinical Guidelines
181
Public Health
115
Key Resources
83
Women & Child Health
77
Pharmacy & Technologies
55
Capacity Building
26
Toolboxes
HIV
138
AMR
138
COVID-19
137
Pharmacy
131
Mental Health
114
TB
114
NTDs
90
Planetary Health
81
NCDs
43
Caregiver
42
Malaria
42
Ebola & Marburg
41
Rapid Response
34
Global Health Education
34
Disability
33
Health Financing Toolbox
32
Conflict
27
Specific Hazards
18
Refugee
17
2.0 Rapid Response
14
Zika
13
Natural Hazards
12
Cholera
7
Social Ethics
5
Polio
3
Department of Behavioural Medicine, Lagos State University College of Medicine Ikeja, Lagos Nigeria
Global Mental Health (2015), 2, e5, page 1 of 12. doi:10.1017/gmh.2015.8;
Received 29 January
...
Principles and Target Product Criteria. Roadmap January 12, 2015
Oxygen is an essential medicine required at all levels of the health care system; only high quality, medical-grade oxygen should be given to patients. Pressure swing adsorption (PSA) oxygen generating plants are a source of medical-grade oxygen. Th
...
WHO Model Formulary
recommended
For each medicine the Formulary provides information on use, dosage, adverse effects, contraindications and warnings, supplemented by guidance on selecting the right medicine for a range of conditio
...
This guidance should be followed if an unlicensed medicine is prepared in
a registered pharmacy. The preparation of an unlicensed medicine (for
example unlicensed methadone, or menthol in aqueou
...
The Atlas of health and climate is a product of this unique collaboration between the meteorological and public health communities. It provides sound scientific information on the connections between weather and climate and major health challenges.
...
The aim of these Guidelines is to provide a framework for the conservation and sustainable use of plants in medicine. To do this, the Guidelines describe the various tasks that should be carried out to ensure that where medicinal plants are taken fr
...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines,
...
For thousands of years, humans have been using wildlife for commercial and subsistence purposes. Wildlife trade takes place at local, national and international levels, with different forms of wildlife, such as live animals, partly processed products and finished products. Wildlife is a vital source
...
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation and Registration (MER) of the East African Community
...
Ethiopia GATS was implemented by Ethiopia Public Health Institute (EPHI) in collaboration with the Ethiopian Food, Medicine, Health Care Administration and Control Authority (FMHACA), CSA, FMOH and the World Health Orga
...
Exciting new treatment approaches make the management of hepatitic C one of the most rapidly developing areas of medicine. The Flying Publisher short Guide to Hepatitis C is an up-to-date source of information for physicians, residents and advanced
...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD
...
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
Since the introduction of penicillin in the early twentieth century, antimicrobial treatments have been utilized not only in human medicine but also in veterinary care – initially to ward off diseases, prevent post-surgery infections,
...
The aim of this protocol is to support the conduct of entomological comparative efficacy assessments for vector control products and the associated non-inferiority analysis. This evidence is used to inform discussions within the guidelines development context as to whether a new vector control
...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
